Ekuinas CEO Datuk Syed Yasir Arafat Syed Abd Kadir
KUALA LUMPUR: Ekuiti Nasional Bhd (Ekuinas) has acquired an 80 per cent stake in Symbiotica Speciality Ingredients Sdn Bhd (Symbiotica), a leading homegrown active pharmaceutical ingredient (API) manufacturer in Southeast Asia (SEA).
Ekuinas chief executive officer Datuk Syed Yasir Arafat Syed Abd Kadir said the pharmaceutical industry is a significant economic contributor with remarkable growth potential. APIs have been identified as a key growth segment for the pharmaceutical sector in the New Industrial Masterplan (NIMP) 2030.
